Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Getinge AB Comments On FY 2013 Earnings Guidance-Conference Call
Getinge AB announced that it expects to deliver a solid year with good earnings growth, despite having to absorb negative currency effect and the effect of the medical device tax, which combined, will broaden projections with about SEK300 million. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of SEK13.32 for fiscal 2013.
Latest Key Developments in Medical
- Biomerieux SA Receives CE Marking For VIDAS 3, The New Generation Of VIDAS
- CryoLife Inc Receives Conditional IDE Approval To Begin Clinical Trials For PerClot In The U.S.
- Essilor International SA Acquires Eight Businesses
- MIT Capital Inc Proposes To Acquire Meade Instruments Corp For $3.65 Per Share In Cash
- Share this
- Link this
- Digg this
Follow Reuters